Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Fisher

Showing results (61-70 of 498) with videos related to

Pageof 50
Sort By:
Current Opinion in Nephrology and Hypertension|July 1, 1993
OKT3 monoclonal antibodies induce interleukin-6 and interleukin-10: a possible cause of lymphoproliferative disorders associated with transplantationL J Swinnen, R I Fisher
Menopause (New York, N.Y.)|July 13, 2016
Measuring hot flash phenomenonology using ambulatory prospective digital diariesWilliam I Fisher, Rebecca C Thurston
The Surgical Clinics of North America|February 1, 1978
Chemotherapy of ovarian cancerR I Fisher, R C Young
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1989
Functional heterogeneity of Leu 19"bright"+ and Leu 19"dim"+ lymphokine-activated killer cellsT M Ellis, R I Fisher
Voprosy Kurortologii, Fizioterapii, I Lechebnoi Fizicheskoi Kultury|January 1, 1974
[25th anniversary of the Saratov Medical Society of Physiotherapists and Health Resort Specialist]L I Fisher, V N Stepanishcheva
The West Virginia Medical Journal|August 1, 1977
Malignant melanoma: prognostic factors and therapeutic resultsV T DeVita, R I Fisher
Current Opinion in Oncology|August 9, 2006
The emerging concept of antigen-driven lymphomas: epidemiology and treatment implicationsSusan G Fisher, Richard I Fisher
Klinicheskaia Meditsina|December 1, 1975
[Basic trends of antituberculosis work under modern conditions]M I Oĭfebakh, Iu I Fisher
The Journal of Burn Care & Rehabilitation|April 17, 2001
Development, reliability, and concurrent validity of the modified inventory of potential reconstructive needsI Fisher, J Strong, Z Tyack
Current Opinion in Oncology|October 1, 1991
Chemotherapy and combined modality treatment in Hodgkin's diseaseE R Gaynor, R I Fisher
Pageof 50

Showing results (61-70 of 498) with videos related to

Sort By:
Pageof 50
Current Opinion in Nephrology and Hypertension|July 1, 1993
OKT3 monoclonal antibodies induce interleukin-6 and interleukin-10: a possible cause of lymphoproliferative disorders associated with transplantationL J Swinnen, R I Fisher
Menopause (New York, N.Y.)|July 13, 2016
Measuring hot flash phenomenonology using ambulatory prospective digital diariesWilliam I Fisher, Rebecca C Thurston
The Surgical Clinics of North America|February 1, 1978
Chemotherapy of ovarian cancerR I Fisher, R C Young
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1989
Functional heterogeneity of Leu 19"bright"+ and Leu 19"dim"+ lymphokine-activated killer cellsT M Ellis, R I Fisher
Voprosy Kurortologii, Fizioterapii, I Lechebnoi Fizicheskoi Kultury|January 1, 1974
[25th anniversary of the Saratov Medical Society of Physiotherapists and Health Resort Specialist]L I Fisher, V N Stepanishcheva
The West Virginia Medical Journal|August 1, 1977
Malignant melanoma: prognostic factors and therapeutic resultsV T DeVita, R I Fisher
Current Opinion in Oncology|August 9, 2006
The emerging concept of antigen-driven lymphomas: epidemiology and treatment implicationsSusan G Fisher, Richard I Fisher
Klinicheskaia Meditsina|December 1, 1975
[Basic trends of antituberculosis work under modern conditions]M I Oĭfebakh, Iu I Fisher
The Journal of Burn Care & Rehabilitation|April 17, 2001
Development, reliability, and concurrent validity of the modified inventory of potential reconstructive needsI Fisher, J Strong, Z Tyack
Current Opinion in Oncology|October 1, 1991
Chemotherapy and combined modality treatment in Hodgkin's diseaseE R Gaynor, R I Fisher
Pageof 50